parkinson-disease

Documents about parkinson-disease

• Multitarget brain implants enable generalized decoding of Parkinson’s disease symptoms from chronic home recordings#217727Europe PMC
• Force control deficits in rapid eye movement behavior disorder and Parkinson's disease.#224770NCBI PubMed Central
• Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment#226776HAL (France)
• Sensorimotor basal ganglia circuit asymmetry explains lateralized motor dysfunction in early Parkinson's disease#234323bioRxiv / medRxiv
• The Clinical Effect of Annonaceae Fruit Consumption on Caribbean Parkinson's Disease Severity.#235941NCBI PubMed Central
• Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT).#242175NCBI PubMed Central
• Immortal time bias from conditioning on future events in Parkinson's disease survival analysis#253620Europe PMC
• Synaptic vesicle architecture modulates α-synuclein conformation and pathogenic transitions in Parkinson's disease.#285118NCBI PubMed Central
• Digital measurement of ocular microtremor in Parkinson's Disease: Analytical and clinical validation.#295031NCBI PubMed Central
• Neuromodulation-induced normalization of cortical metastable dynamics signatures in Parkinson's disease.#297361NCBI PubMed Central
• Prevalence and Clinical Determinants of Cognitive Impairment in Diverse Patients with Parkinson's Disease#332428bioRxiv / medRxiv
• Dataset supporting a study of cognition, emotion regulation, and mental health in Parkinson’s Disease#339291University of Reading Research Data Archive
• Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review.#342371NCBI PubMed Central
• Parkinson's disease participant-led research: Towards neuroimaging-assisted deep brain stimulation programming.#360857NCBI PubMed Central
• Entrainment of cortical gamma oscillations predicts improved bradykinesia and dyskinesia in Parkinson's disease#377132bioRxiv / medRxiv
• Enhancing prediction accuracy for Parkinson's disease using advanced machine learning models.#382493NCBI PubMed Central
• Beyond motor: a systematic review of multisensory integration deficits in Parkinson's disease.#425068NCBI PubMed Central
• Toward the prevention of clinically manifest Parkinson’s disease#428755Springer Nature OA
• Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease#475801Europe PMC
• Relationship between stage and strength for people with Parkinson's Disease#488695SJSU ScholarWorks
• Unconstrained detection of freezing of Gait in Parkinson's disease patients using smartphone#654945S-Space: Seoul National University
• Proteo-metabolomic integration identifies stage-specific candidate biomarkers for Parkinson's disease.#662745NCBI PubMed Central
• A systematic review of the clinical correlates of delusions in Parkinson's disease.#678266NCBI PubMed Central
• A meta-analysis of periodic and aperiodic electrophysiological features in Parkinson's disease.#685455NCBI PubMed Central
• Study to Evaluate Initiation of Stalevo in Early Wearing-off#801701ClinicalTrials.gov
• Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations#827549ClinicalTrials.gov
• A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects#827812ClinicalTrials.gov
• Asleep Versus Awake Deep Brain Stimulation Surgery#853153ClinicalTrials.gov
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies.#121227PubMed
• Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease#486474Directory of Open Access Books
• 38 U.S.C. § 7329 — Parkinson’s Disease research, education, and clinical centers#587933US Code (LII)
• Use of machine learning and voice for multiclass classification of Parkinson's disease, chronic obstructive pulmonary disease, and healthy controls.#213975NCBI PubMed Central
• Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease.#223084NCBI PubMed Central
• Clinical characteristics and predictors of disease progression in parkinson's disease in a cohort of patients in the ashanti region, Ghana.#267001NCBI PubMed Central
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.#366530ClinicalTrials.gov
• Microbiota-Gut-Brain Axis in Neurodegenerative Diseases: The Role of Bacterial Amyloids#471980HAL (France)
• L-Dopa-induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson’s disease#364181HAL (France)
• A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension#838117ClinicalTrials.gov
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study#826957ClinicalTrials.gov
• Assessment of Social-emotional Functioning in Neurological Diseases#855618ClinicalTrials.gov
• Data Sheet 1_Which exercise intervention is most promising for Parkinson's balance? A network meta-analysis.zip#367147Figshare
• Basal Forebrain Volume and Concurrent Hallucinations and Mild Cognitive Impairment in Parkinson's Disease.#9028NCBI PubMed Central
• Retraining gait in Parkinson’s Disease via a personalised app: A study protocol.#15175NCBI PubMed Central
• Uncovering sex differences in Parkinson's Disease through metaanalysis of single cell transcriptomic studies#134305bioRxiv / medRxiv
• Objective Predictors of Visual Quality of Life in Parkinson’s Disease#135518Unpaywall
• Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2#138330Unpaywall
• Multimodal Intelligent Monitoring of Parkinson Disease: Scoping Review of Progress and Translational Challenges.#151420NCBI PubMed Central
• Rare-Variant Burden Analysis of Dystonia Genes in Parkinson’s Disease#157803Unpaywall
• Pathological cortico-STN beta coupling in Parkinson's disease is confined to beta bursts#176515bioRxiv / medRxiv
• Intermittent Theta-Burst Stimulation for Depressive Symptoms in Parkinson Disease: A Randomized Clinical Trial.#218796NCBI PubMed Central